Trans India House Impex Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Trans India House Impex Ltd is ₹ 3.71 as of 03 Aug 10:45 . The P/E Ratio of Trans India House Impex Ltd is 43.4 as of March 2025 .The P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd is 0 as of March 2025 . The Market Cap of Trans India House Impex Ltd is ₹ 44.73 crore as of March 2025 .The Market Cap of Welcure Drugs & Pharmaceuticals Ltd is ₹ 0 crore as of March 2025 . The revenue of Trans India House Impex Ltd for the Jun '26 is ₹ 2 crore as compare to the Mar '26 revenue of ₹ 25.6 crore. This represent the decline of -92.19% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Trans India House Impex Ltd for the Jun '26 is ₹ 0.37 crore as compare to the Mar '26 ebitda of ₹ 2.64 crore. This represent the decline of -85.98% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Trans India House Impex Ltd changed from ₹ 0.24 crore to ₹ -0.12 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The Dividend Payout of Trans India House Impex Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Trans India House Impex Ltd

Trans India House Impex Limited (TIHIL), formerly known as IO System Limited was incorporated on 25 May, 1987.
The name of the Company was changed from IO System Limited to Trans India House Impex Limited in 2022.
TIHIL is a dynamic and integrated international trade conglomerate, specializing in export, import, and merchant trading services.
TIHIL provides comprehensive end-to-end trade solution and are experts in market identification, product sourcing, and seamless transaction execution, ensuring efficient and profitable trade operations for the partners.
The core portfolio includes the trade of Ceramic Tiles, Textiles, Fabrics, and Fast-Moving Consumer Goods (FMCG). In the initial years, Company had entered into a joint venture(JV) agreement with the General Binding Corporation (GBC), USA on 19 June, 1988 for manufacturing and selling office Automation products.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Trans India House Impex Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Trans India House Impex Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Trans India House Impex Ltd is 18 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Trans India House Impex Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Trans India House Impex Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Trans India House Impex Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 31, 2026, the Trans India House Impex Ltd stock price is INR ₹2.6. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Trans India House Impex Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Trans India House Impex Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.